Scott Buzin, DO
Orthopedic Surgery · Jersey City, NJNPI 1619330735
Payments from drug & device makers
What this record shows
The money is spread across several categories — education (49.6%), grants and food and beverage — rather than concentrated in one kind of arrangement. 5 manufacturers reported payments, led by Arthrex at 54.4% of the total. Reporting peaked in 2022 at $37,784 and has fallen 99.4% since, to $219 in 2025. Among orthopedic surgery clinicians in NJ with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 50 payments — averaging $909.84 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Arthrex$25K
- Smith+Nephew$15K
- Gotham Surgical Solutions & Devices, Inc.$4K
- Polaris Technology Solutions LLC$1K
- Stryker$498
What the payments were for
- Grants$20,00044%
- Travel & lodging$6741%
- Food & beverage$2,2435%
- Education$22,57550%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Arthrex | 26 | $24,740 |
| Smith+Nephew | 7 | $14,798 |
| Gotham Surgical Solutions & Devices, Inc. | 10 | $4,182 |
| Polaris Technology Solutions LLC | 2 | $1,274 |
| Stryker | 5 | $498 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$45,492 in reported general payments places this provider in the 95th percentile of 32 orthopedic surgery providers in New Jersey.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Meloxicam | 64 | $168 |
Paid to pharmacies, not to this prescriber.
Other orthopedic surgery in Jersey City
- Frank FeminoNutley$18K
- Mark RuoffWayne$9K
- Andrew WillisMorristown$8K
- David EingornHamilton$7K
- Andrew McGinnissNewark$5K
- Paul LombardiMorristown$4K
- Charles GattoMorristown$4K
- Calvin MatthewsBloomfield$4K
- David BaschSparta$3K
- Mark McBrideMorristown$3K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.